Wong, Founder and CEO of HCW Biologics, stated, “In the third quarter 2024, the Company expanded our product portfolio and possible disease indications that may be treated with our immunotherapeutic ...

General Mills' recent acquisitions, particularly in pet food, raise concerns. See why GIS stock remains attractive, but strategic issues linger.

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

A Profitable Path to Growth in High-Traffic Locations,” will offer expert insight at the Self Service Innovation Summit being ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

CloseCurlyDoubleQuote; Net revenues were $56 thousand for the quarter ended September 30, 2024, a decrease of $24 thousand from $80 thousand for the same period in 2023. Net revenues ... Designation ...

Nomad Foods reports Q3 sales growth of 0.8%, beats EPS estimates, but lowers FY24 revenue growth outlook due to ERP ...

Accordingly, the correct GST rate for this category was determined to be 18%. The AAR also rejected the applicant’s claim of ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first purchase order for LockeT ...

Holiday spending is expected to rise from last year's record high, despite elevated inflation. Morgan Stanley shared 14 ...